Author:
Boostrom Sarah Y.,Nagorney David M.,Donohue John H.,Harmsen Scott,Thomsen Kristine,Que Florencia,Kendrick Michael,Reid-Lombardo Kaye M.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. SEER Cancer Statistics Review, 1975–2003, LAG Ries, et al., Editors. 2006, National Cancer Institute: Bethesda, MD, http://seer.cancer.gov/csr/1975_2003/ , based on November 2005 SEER data submission, posted to the SEER web site. p. 1–25.
2. Lee JJ, Chu E. An update on treatment advances for the first-line therapy of metastatic colorectal cancer. Cancer J 2007;13:276–281.
3. Barone C, Nuzzo G, Cassano A, Basso M, Schinzari G, Giuliante F, D'Argento E, Trigila N, Astone A, Pozzo C. Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer 2007;97:1035–1039.
4. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309–318. discussion 318–321.
5. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509–520. discussion 520–522.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献